Adaptimmune raised €79M in a Series A round in Sep 2014. The company is based in Milton, UK. Investors in the round: New Enterprise Associates, Novo A, S and 1 other. Data as of 7 Aug 2026.
No source on record — unverified.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.
